{"ticker": {"uuid": "fdac9d6f-d683-44f3-ad28-dfbb55fe934d", "symbol": "ROP", "name": "Roche Holding AG", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Roche (SWX:ROP) Stock May Still Be A Bargain On A 32% Run", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRlRqNy1fUEkxZ1BjeUNaQWNUak9vSVNHOEpqMElob2g0dXFrRkNTM3FWQm9WSWM3UkhtNXNGX2oxNGpyV2x4OGNzUkRGSVlNbTd5NDdiLUNDN3lUZmdaTjJaUVcxMWpQNnhOWVZVa0tvZFVNclJzWXUyMklkdHdHVHpyYnFERnpDcEhHaXJFcDBlUQ?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "C4 yourself: $1B second Roche deal evidence of DAC faith", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPVDdGbThVNG5oajVPcE5pM1p1aUFiUVphanhHWXFtS0FhdTA3TEtJNEJSOV9zMnVxd3J4bldKRzdpTERTRDhoVUxHLXN3NktWcGFaR1NHUzdSanM4cmhXX1pFVy04eXBqQWlhX1FITVZwTG5YWHZiZW9jTW5xVmE5Vlh2Skp0N01CbFVoVlBZS3VoVkFSUWduaHBFQQ?oc=5", "source_name": "BioWorld News", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Risdiplam generic drug case: SC rejects Roche plea against Natco pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche acquires 89bio for US$3.5bn", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOQzBIV2JZTHd6V25VSWZEVVR2WGlVVFFJTU45N0x3bFVkeWRid1d0SGNkdVdlSGl3ck9Ca0Y1emYxR29vRHdaU0MwNFdSNlJ0bm96aWNMRzdqaUZBeFRvdUlRTURQdFl1Q2s4aFRvQ3VBODdkcTQzd212SWU1N2lHSE9KWHhBN1U?oc=5", "source_name": "European Biotechnology Magazine", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Roche a Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE8yWUVxa2FBclQ2azI0SlN2X3FlNGJGNVRWdnhRUUJQUk8xMkxzeHc0QlFMODlDRUN5RFZ1b2VMWHRkMzVRekVhRXB5aGJOd1lIZnpETGZDTjJBWXFrZE5CRTQxVmtmdWh2VE1JNFNR?oc=5", "source_name": "The Motley Fool", "published_at": "2023-03-20T07:00:00+00:00", "published_display": "20 Mar 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Names Roche's O'Day as CEO and Chairman", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5DQnRPUTU0X1hRLTVpYmhkWVZ4R1RRYm80Xzdobkk3ZkRuSDFsaDh0aGJtOXdmM2NlN2hzUFJsSTBuSTVfcEdpM3NJUW1SZXQ4S293RjhOdGpYN2dEcTZ2ekw4OFR6QmxneG96QnpJTl9wRks2azBpdHlzR3hudDA?oc=5", "source_name": "thestreet.com", "published_at": "2018-12-10T08:00:00+00:00", "published_display": "10 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche agrees to pay $2.4 billion to buy the rest of Foundation Medicine", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC", "published_at": "2018-06-19T07:00:00+00:00", "published_display": "19 Jun 2018 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche reports deaths of patients taking Hemlibra", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUExYdFpGVk1QU3c2NVA5WDdYcEctN2lNTUtQMC1wemhsbDNicnYxYW43SXBRZldacGphRHpkTFVJNTZLQndRTmRzbW5KQzRhLVhrSC14TDRmV1ZrQlpIT2NHMDh1M3hUMkx4bkVEYkdlbFhoRElBTmlPdHFoWHdTLXNMcTlWb2VyeXpDTTluekFaS3V1VnRXNDktLUNTRkE?oc=5", "source_name": "BioPharma Dive", "published_at": "2018-03-28T07:00:00+00:00", "published_display": "28 Mar 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Despite trial win, Roche\u2019s new eye drug can\u2019t escape Eylea\u2019s shadow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQXzlvdGxXTktQZnBVcHF6YUNISWRTV0xOZllsM0dtbkRRLTdidHpSbl94ajdUZk43R25jSHhlMTIzSFF6SmU2cHllT25nS21jV3Z5Q3Q1Z1FaWGR4MTZtY0F4MHFDdldXaHMzS2xOeDYtUUJWZ19mTEVPOG5jQWZLS1dRN1JGRl9WTWdFVVF1ZVVhVHlENnJNOHQ0LU5mRlB2YlhPVHdxckVKZw?oc=5", "source_name": "BioPharma Dive", "published_at": "2018-02-12T08:00:00+00:00", "published_display": "12 Feb 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transnational Roche Selects Escaz\u00fa Village to House Costa Rican IT Service Center", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNa0Z4SGppaWNfVUxkS0lPUHJONTFhOVBteG5PM2ViRHB5R2NwR1B4TEg1blNHVWQ3RTFGd19ORkRKclFJbTZYTDBnbm5CZ2RlUXcwMHotc0R4M1Fhc2hJa2JIZmxhdTVNT2tINmZDM01nX2x3R1JLY3B3QlRnMkRMNElia1pxcktmbG9nNUhJNUY5am12Y0NRNHJ4UHZtQmdCZkJ6aDJibU1kcGM?oc=5", "source_name": "Costa Rica Star News", "published_at": "2017-09-01T01:13:14+00:00", "published_display": "01 Sep 2017 01:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Roche (SWX:ROP) Stock May Still Be A Bargain On A 32% Run", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRlRqNy1fUEkxZ1BjeUNaQWNUak9vSVNHOEpqMElob2g0dXFrRkNTM3FWQm9WSWM3UkhtNXNGX2oxNGpyV2x4OGNzUkRGSVlNbTd5NDdiLUNDN3lUZmdaTjJaUVcxMWpQNnhOWVZVa0tvZFVNclJzWXUyMklkdHdHVHpyYnFERnpDcEhHaXJFcDBlUQ?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "C4 yourself: $1B second Roche deal evidence of DAC faith", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPVDdGbThVNG5oajVPcE5pM1p1aUFiUVphanhHWXFtS0FhdTA3TEtJNEJSOV9zMnVxd3J4bldKRzdpTERTRDhoVUxHLXN3NktWcGFaR1NHUzdSanM4cmhXX1pFVy04eXBqQWlhX1FITVZwTG5YWHZiZW9jTW5xVmE5Vlh2Skp0N01CbFVoVlBZS3VoVkFSUWduaHBFQQ?oc=5", "source_name": "BioWorld News", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Risdiplam generic drug case: SC rejects Roche plea against Natco pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche acquires 89bio for US$3.5bn", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOQzBIV2JZTHd6V25VSWZEVVR2WGlVVFFJTU45N0x3bFVkeWRid1d0SGNkdVdlSGl3ck9Ca0Y1emYxR29vRHdaU0MwNFdSNlJ0bm96aWNMRzdqaUZBeFRvdUlRTURQdFl1Q2s4aFRvQ3VBODdkcTQzd212SWU1N2lHSE9KWHhBN1U?oc=5", "source_name": "European Biotechnology Magazine", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Roche a Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE8yWUVxa2FBclQ2azI0SlN2X3FlNGJGNVRWdnhRUUJQUk8xMkxzeHc0QlFMODlDRUN5RFZ1b2VMWHRkMzVRekVhRXB5aGJOd1lIZnpETGZDTjJBWXFrZE5CRTQxVmtmdWh2VE1JNFNR?oc=5", "source_name": "The Motley Fool", "published_at": "2023-03-20T07:00:00+00:00", "published_display": "20 Mar 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Names Roche's O'Day as CEO and Chairman", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5DQnRPUTU0X1hRLTVpYmhkWVZ4R1RRYm80Xzdobkk3ZkRuSDFsaDh0aGJtOXdmM2NlN2hzUFJsSTBuSTVfcEdpM3NJUW1SZXQ4S293RjhOdGpYN2dEcTZ2ekw4OFR6QmxneG96QnpJTl9wRks2azBpdHlzR3hudDA?oc=5", "source_name": "thestreet.com", "published_at": "2018-12-10T08:00:00+00:00", "published_display": "10 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche agrees to pay $2.4 billion to buy the rest of Foundation Medicine", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC", "published_at": "2018-06-19T07:00:00+00:00", "published_display": "19 Jun 2018 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche reports deaths of patients taking Hemlibra", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUExYdFpGVk1QU3c2NVA5WDdYcEctN2lNTUtQMC1wemhsbDNicnYxYW43SXBRZldacGphRHpkTFVJNTZLQndRTmRzbW5KQzRhLVhrSC14TDRmV1ZrQlpIT2NHMDh1M3hUMkx4bkVEYkdlbFhoRElBTmlPdHFoWHdTLXNMcTlWb2VyeXpDTTluekFaS3V1VnRXNDktLUNTRkE?oc=5", "source_name": "BioPharma Dive", "published_at": "2018-03-28T07:00:00+00:00", "published_display": "28 Mar 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Despite trial win, Roche\u2019s new eye drug can\u2019t escape Eylea\u2019s shadow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQXzlvdGxXTktQZnBVcHF6YUNISWRTV0xOZllsM0dtbkRRLTdidHpSbl94ajdUZk43R25jSHhlMTIzSFF6SmU2cHllT25nS21jV3Z5Q3Q1Z1FaWGR4MTZtY0F4MHFDdldXaHMzS2xOeDYtUUJWZ19mTEVPOG5jQWZLS1dRN1JGRl9WTWdFVVF1ZVVhVHlENnJNOHQ0LU5mRlB2YlhPVHdxckVKZw?oc=5", "source_name": "BioPharma Dive", "published_at": "2018-02-12T08:00:00+00:00", "published_display": "12 Feb 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transnational Roche Selects Escaz\u00fa Village to House Costa Rican IT Service Center", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNa0Z4SGppaWNfVUxkS0lPUHJONTFhOVBteG5PM2ViRHB5R2NwR1B4TEg1blNHVWQ3RTFGd19ORkRKclFJbTZYTDBnbm5CZ2RlUXcwMHotc0R4M1Fhc2hJa2JIZmxhdTVNT2tINmZDM01nX2x3R1JLY3B3QlRnMkRMNElia1pxcktmbG9nNUhJNUY5am12Y0NRNHJ4UHZtQmdCZkJ6aDJibU1kcGM?oc=5", "source_name": "Costa Rica Star News", "published_at": "2017-09-01T01:13:14+00:00", "published_display": "01 Sep 2017 01:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 11, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 9, "score": 53, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 6.55, "count": 10}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 336.6, "latest_week": "2026-07-10", "one_week_move": -1.2, "four_week_move": 2.0, "twelve_week_move": 5.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.478626, "market_dynamics_buy_signal": false, "relative_strength": 1.426419, "fair_value_gap": 29.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 59.4976, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.2% over one week, +2.0% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Standard", "count": 2}, {"label": "BioPharma Dive", "count": 2}, {"label": "Market source", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "European Biotechnology Magazine", "count": 1}, {"label": "The Motley Fool", "count": 1}, {"label": "thestreet.com", "count": 1}, {"label": "CNBC", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.2% over one week, +2.0% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Roche (SWX:ROP) Stock May Still Be A Bargain On A 32% Run"}], "updated_at": "2026-07-18T02:10:28.270466+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}